A Trial to Assess Expanded Safety, Acceptability and Preliminary Effectiveness of Carraguard (PC-515) in Preventing STI/HIV Transmission

Trial Profile

A Trial to Assess Expanded Safety, Acceptability and Preliminary Effectiveness of Carraguard (PC-515) in Preventing STI/HIV Transmission

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Aug 2017

At a glance

  • Drugs PC 515 (Primary)
  • Indications Gonorrhoea; HIV infections; Trachoma; Treponema infections; Trichomoniasis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 18 Feb 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top